These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2869673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF, Cheron P, Nannan M, Vincent MF, Lavenne F, Pouleur H.
    Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic effects of ICI 118.587 (Corwin) in patients with mild cardiac failure after myocardial infarction.
    Svensson G, Rehnqvist N, Sjögren A, Erhardt L.
    J Cardiovasc Pharmacol; 1985; 7(1):97-101. PubMed ID: 2580158
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Myocardial energetics in dilated cardiomyopathy.
    Thierfelder L, Holubarsch CH, Hasenfuss G, Just HJ.
    Clin Cardiol; 1990 Sep; 13(9):649-54. PubMed ID: 1976466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of xamoterol on myocardial energetics in man.
    Sakai O, Fujita M, Sasayama S, Asanoi H, Nakajima H, Yokawa S.
    Jpn Circ J; 1988 Feb; 52(2):149-54. PubMed ID: 2896256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ, Davies MK.
    Br J Clin Pharmacol; 1989 Feb; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
    Pouleur H, Hanet C, Rousseau MF.
    Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
    [Abstract] [Full Text] [Related]

  • 15. Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
    Boström PA, Johansson BW, Lecerof H, Lilja B, Torp A.
    Eur Heart J; 1990 Apr; 11 Suppl A():45. PubMed ID: 1971588
    [No Abstract] [Full Text] [Related]

  • 16. Acute and chronic effects of xamoterol in idiopathic dilated cardiomyopathy.
    Watanabe K, Hirokawa Y, Suzuki K, Shibata A.
    Jpn Heart J; 1988 Sep; 29(5):603-15. PubMed ID: 2975712
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Haemodynamic effects of ICI 118,587 in cardiomyopathy.
    Simonsen S.
    Br Heart J; 1984 Jun; 51(6):654-7. PubMed ID: 6145436
    [Abstract] [Full Text] [Related]

  • 20. Antianginal effects of corwin, a new beta-adrenoceptor partial agonist.
    Detry JM, Decoster PM, Buy JJ, Rousseau MF, Brasseur LA.
    Am J Cardiol; 1984 Feb 01; 53(4):439-43. PubMed ID: 6141726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.